https://www.marketscreener.com/quote/stock/GALENA-BIOPHARMA-INC-11900113/news/Galena-Biopharma-Presents-Positive-GALE-301-Phase-2a-Clinical-Trial-Data-at-the-European-Cancer-Cong-21106165/?utm_source=telegram&utm_medium=social&utm_campaign=share